Interim Report 2026
Filed with HKEX · Stock code 3320 · · 111 pages · English and Chinese
China Resources Pharmaceutical Group Ltd. on 6ix
Earlier from China Resources Pharmaceutical
- Dividend currency election form for the interim dividend for the six months ended 30 June 2026
- AilsynBio and Dong-E-E-Jiao Sign Project Cooperation Agreement Empowering Traditional Medicine with AI to Open a New Chapter in the Health Industry
- Announcement unaudited financial results of jiangzhong pharmaceutical for the six months ended 30 June 2021
- China Resources Pharmaceutical Group: Unaudited financial results of cr pharmaceutical holdings for the three months ended 31 March 2021 in relation to issuances of corporate bonds and medium term notes in the prc
- Announcement unaudited financial results of cr sanjiu for the three months ended 31 March 2021
Later from China Resources Pharmaceutical
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Inside information potential issuance of shares by CR pharmaceutical commercial
- Inside information completion of the public issuance of the second tranche of 2026 corporate bonds in the PRC
Follow China Resources Pharmaceutical into a list and get an email when it puts out news.
Follow China Resources Pharmaceutical